Resources

Cover page in blue with title and image of people sitting on the ground listening to.a training

Microplanning manual to guide implementation of preventive chemotherapy to control and eliminate neglected tropical diseases

WHO manual on implementing preventative chemotherapy against neglected tropical diseases provides generic tools for those involved in planning preventative chemotherapy administration. The publication was released in September 2022.
Cropped image of document cover page

WHO standard operating procedures for supply chain management of health products for neglected tropical diseases amenable to preventive chemotherapy

New WHO standard operating procedures--released on July 25, 2022--describes the standard operating procedures for health products for NTDs amenable to preventive chemotherapy and the medicines donated to treat them.
Cover of WHO Guideline

WHO guideline on control and elimination of human schistosomiasis

New WHO guideline--released on February 14, 2022--outlines guidelines for preventive chemotherapy, safety of praziquantel for treatment, WASH and snail control interventions and verification of interruption of transmission of human schistosomiasis. 

figure from study article

Effect of preventive chemotherapy with praziquantel on SCH among school age children in sub-Saharan Africa: a spatiotemporal modelling study

Christos Kokaliaris, Amadou Garba, Martin Matuska, Rachel N Bronzan, Daniel G Colley, Ameyo M Dorkenoo, Uwem F Ekpo, Fiona M Fleming, Michael D French, Achille Kabore, Jean B Mbonigaba, Nicholas Midzi, Pauline N M Mwinzi, Eliézer K N'Goran, Maria Rebollo Polo, Moussa Sacko, Louis-Albert Tchuem Tchuenté, Edridah M Tukahebwa, Pitchouna A Uvon, Guojing Yang, Lisa Wiesner, Yaobi Zhang, Jürg Utzinger, Penelope Vounatsou, Effect of preventive chemotherapy with praziquantel on schistosomiasis among school-aged children in sub-Saharan Africa: a spatiotemporal modelling study, The Lancet Infectious Diseases, 2021, ISSN 1473-3099, https://doi.org/10.1016/S1473-3099(21)00090-6.
Trachoma Surveys: Practical Approaches to Implementing WHO Guidance for Neglected Tropical Disease (NTD) Programs in the Context of COVID-19

Trachoma Surveys: Practical Approaches to Implementing WHO Guidance for Neglected Tropical Disease (NTD) Programs in the Context of COVID-19

Trachoma baseline surveys, trachoma impact surveys, trachoma surveillance surveys, and trichiasis-only surveys are key disease-specific assessments of trachoma elimination programs, used to start mass drug administration (MDA), monitor progress, decide when to stop MDA, and inform attainment of elimination of trachoma as a public health problem.
USAID's Act to End NTDs | West's Kisito Ogoussan

Applying a quality improvement model to neglected tropical diseases program implementation: supporting programs in identifying keys for sustaining operations

West African neglected tropical diseases (NTD) programs have made great progress toward the elimination/control of NTDs amenable to preventive chemotherapy. However, some districts have failed impact surveys—notably for lymphatic filariasis and trachoma—due to implementation inadequacies, despite reporting good mass treatment coverage. A quality improvement framework has been initiated to strengthen country program interventions and address issues that hinder their ability to achieve the World Health Organization NTD road map elimination/control goals.  The workshop aims to present an innovative model for improving implementation and discuss ideas, strategies, and plans for initiating quality improvement (QI) activities. Experiences from Ghana and Sierra Leone in the design and implementation of the QI model will be shared. 
Model overview

Considerations for developing and deploying cost and economic impact models in the elimination/control of 5 PCT NTDs

The economic impact model and supporting disease-specific tools estimate the direct and indirect economic impact, efficiencies, and societal benefits of investing in NTD programs and interventions. The workshop will explain how NTD programs can use the supporting tools to develop investment cases to advocate for domestic resources and prioritize NTD investments in a multi-disease environment. It will also describe how, with support from HKI and Deloitte, Sierra Leone’s NTD program will pilot these tools and serve as the advisor on country needs, program and financial data, user testing of the tools, and utilization of the outputs for advocacy. After incorporating the feedback from the pilot in Sierra Leone, the Act | West team will make the tools available to all supported countries to create investment cases that enhance advocacy efforts for domestic resource mobilization for NTD programming.